Related Experiment Video
Updated: Jun 1, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Intensive glycemic control and renal outcome
Contributions to Nephrology
|June 11, 2011
Summary
Intensive glycemic control benefits early diabetic kidney disease, but its effect on advanced stages remains unclear. Individualized glucose management is recommended for patients with reduced kidney function due to hypoglycemia risks.
Area of Science:
- Nephrology
- Endocrinology
- Diabetology
Background:
- Diabetes is a primary cause of chronic kidney disease (CKD), leading to end-stage renal disease in up to 50% of cases.
- High morbidity and mortality risks exist for individuals with both diabetes and CKD, emphasizing prevention and management.
- Inadequate glycemic control is linked to adverse outcomes in diabetes, with early studies suggesting benefits from tighter control.
Purpose of the Study:
- To review the established benefits of intensive glycemic control in early diabetic nephropathy (DN).
- To address the controversy surrounding intensive glycemic control's efficacy in established DN and reduced glomerular filtration rates.
- To highlight safety concerns, such as hypoglycemia, associated with intensive therapy in patients with CKD stages 3-5.
Main Methods:
- Review of observational studies and large clinical trials on glycemic control and diabetic complications.
- Analysis of evidence regarding microvascular outcomes, including microalbuminuria, in type 1 and type 2 diabetes.
- Evaluation of safety data, particularly severe hypoglycemia, in diabetic patients with varying degrees of kidney function.
Main Results:
- Intensive glycemic therapy demonstrably reduces the incidence and progression of microvascular complications, including early-stage DN.
- Evidence is less conclusive regarding the benefits of intensive glycemic control for slowing the progression of established DN in patients with reduced glomerular filtration rates.
- Severe hypoglycemia is a significant safety concern associated with intensive glycemic therapy, especially in patients with advanced CKD (stages 3-5).
Conclusions:
- Intensive glycemic therapy is beneficial for preventing and managing early-stage diabetic nephropathy.
- An individualized approach to glucose management is crucial for patients with reduced glomerular filtration rates, balancing glycemic control benefits against hypoglycemia risks.
- Further research is needed to clarify the role and safety of intensive glycemic control in advanced diabetic kidney disease.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...